/
/
/

Aspira Pathlab & Diagnostics Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%

Share Price Live Stats

Empty box

No results found

Share Market Cap & Key Ratios Overview

Empty box

No results found

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Empty box

No results found

Key Highlights of Aspira Pathlab & Diagnostics Ltd’s P&L

In 2025-03-31, Aspira Pathlab & Diagnostics Ltd reported total revenue of ₹22.39Cr, compared with ₹13.63Cr in 2024-03-31, reflecting Aspira Pathlab & Diagnostics Ltd turnover.

Depreciation was ₹1.49Cr and finance costs were ₹34.74Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹2.02Cr in 2025-03-31 as compared to ₹-₹2.67Cr in 2024-03-31.

Net Profit (PAT) was ₹2.02Cr in 2025-03-31 compared with ₹-₹2.67Cr in 2024-03-31.

Earnings per share (EPS) were ₹1.97 in 2025-03-31, compared with ₹-2.60 in 2024-03-31.